Identification, Molecular Epidemiology Angiosarcoma of the Liver France (ANGIHE)
Sponsor: Centre Oscar Lambret
Listed as NCT01786889, this NA trial focuses on Angiosarcoma and remains ongoing. Sponsored by Centre Oscar Lambret, it has been updated 7 times since 2013, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Unknown NA
-
Sep 2024 — Sep 2025 [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status NA
-
Aug 2018 — Jan 2021 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
▶ Show 2 earlier versions
-
Jun 2018 — Aug 2018 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
First recorded
Jun 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centre Oscar Lambret
- Institut de Veille Sanitaire
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Bordeaux, France , Clermont-Ferrand, France , Dijon, France , Lille, France , Lyon, France , Marseille, France , Montpellier, France , Paris, France , Saint-Priest-en-Jarez, France , Strasbourg, France and 2 more locations